Alkannin Inhibits the Development of Ovarian Cancer by Affecting miR-4461.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2021;
2021:5083302. [PMID:
34876915 PMCID:
PMC8645362 DOI:
10.1155/2021/5083302]
[Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Accepted: 11/13/2021] [Indexed: 11/17/2022]
Abstract
Background
Previous studies have shown that alkannin has anticancer, anti-inflammatory, and antibacterial effects. However, the effect of alkannin in the development of ovarian cancer (OC) remains unknown. Therefore, this study aims to elucidate the function of alkannin in OC progression.
Methods
RT-qPCR and western blot analysis were used to measure mRNA and protein expression. Cell viability and metastasis were detected by the CCK-8 assay, flow cytometry analysis, and transwell assay.
Results
Alkannin had no cytotoxicity toward normal ovarian cells, but alkannin can inhibit cell proliferation and induce apoptosis in OC cells. In addition, alkannin inhibited cell migration and invasion and blocked EMT in OC. Besides, upregulation of miR-4461 was found in OC tissues and cells, which was regulated by alkannin. More importantly, miR-4461 can inverse the effects of alkannin on cell viability and metastasis in OC cells.
Conclusion
Alkannin restrains cell viability, metastasis, and EMT in OC by downregulating miR-4461 expression.
Collapse